lenalidomide has been researched along with lithium chloride in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (lithium chloride) | Trials (lithium chloride) | Recent Studies (post-2010) (lithium chloride) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 3,883 | 45 | 1,152 |
| Protein | Taxonomy | lenalidomide (IC50) | lithium chloride (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashhab, MU; Gan, N; He, F; Kong, H; Omran, A; Peng, J; Yin, F | 1 |
1 other study(ies) available for lenalidomide and lithium chloride
| Article | Year |
|---|---|
Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy.
Topics: Adolescent; Animals; Astrocytes; Case-Control Studies; Child; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Lenalidomide; Lipopolysaccharides; Lithium Chloride; Male; MicroRNAs; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Thalidomide; Tumor Necrosis Factor-alpha | 2013 |